Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Procter & Gamble R&D on metalloprotease inhibition

June 9, 1998

Abbott and Boehringer Ingelheim sign comarketing agreement

June 9, 1998

Zimmer and Anika expand Orthovisc agreement

June 8, 1998

APHS: a selective COX-2 inhibitor for treating inflammatory and proliferative disorders

June 4, 1998

More work at P&G on metalloprotease inhibitors

June 4, 1998

Genetics Institute claims series with PLA2-inhibitory activity

June 4, 1998

Procter & Gamble prepares inhibitors of mammalian metalloproteases

June 3, 1998

MMP/TNF-alpha convertase inhibitors disclosed by Agouron

June 1, 1998

Preparation and use of MMP/TNF production inhibitors described by Pfizer

May 29, 1998

RCT describes truncated chemokine analogues for rheumatoid arthritis

May 28, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...